X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (13) 13
female (11) 11
male (11) 11
aged (10) 10
middle aged (10) 10
adult (8) 8
administration, inhalation (7) 7
bronchodilator agents - administration & dosage (7) 7
pulmonary disease, chronic obstructive - drug therapy (7) 7
asthma - drug therapy (6) 6
double-blind method (6) 6
bronchodilator agents - adverse effects (5) 5
bronchodilator agents - therapeutic use (5) 5
corticosteroids (5) 5
drug therapy (5) 5
fluticasone (5) 5
lung diseases, obstructive (5) 5
treatment outcome (5) 5
adolescent (4) 4
aged, 80 and over (4) 4
allergy (4) 4
androstadienes - administration & dosage (4) 4
androstadienes - therapeutic use (4) 4
anti-asthmatic agents - therapeutic use (4) 4
asthma (4) 4
benzyl alcohols - administration & dosage (4) 4
chlorobenzenes - administration & dosage (4) 4
copd (4) 4
drug therapy, combination (4) 4
fluticasone propionate (4) 4
immunology (4) 4
index medicus (4) 4
obstructive pulmonary-disease (4) 4
placebo (4) 4
quinuclidines - administration & dosage (4) 4
research (4) 4
respiratory system (4) 4
usage (4) 4
airway inflammation (3) 3
albuterol - analogs & derivatives (3) 3
albuterol - therapeutic use (3) 3
anti-asthmatic agents - administration & dosage (3) 3
antiasthmatic agents (3) 3
beclomethasone (3) 3
care and treatment (3) 3
chronic disease (3) 3
dosage and administration (3) 3
dose-response relationship, drug (3) 3
drug combinations (3) 3
forced expiratory volume (3) 3
lung - drug effects (3) 3
lung - physiopathology (3) 3
montelukast (3) 3
quality of life (3) 3
respiratory function tests (3) 3
salmeterol (3) 3
salmeterol xinafoate (3) 3
time factors (3) 3
acetates - therapeutic use (2) 2
albuterol - administration & dosage (2) 2
albuterol - adverse effects (2) 2
androstadienes - adverse effects (2) 2
androstadienes - pharmacology (2) 2
anti-inflammatory agents - administration & dosage (2) 2
benzyl alcohols - adverse effects (2) 2
benzyl alcohols - therapeutic use (2) 2
bronchodilator agents (2) 2
budesonide (2) 2
chemistry (2) 2
child (2) 2
chlorobenzenes - adverse effects (2) 2
chlorobenzenes - therapeutic use (2) 2
complications and side effects (2) 2
double-blind (2) 2
drug administration schedule (2) 2
efficacy (2) 2
inhaled corticosteroid (2) 2
inhaled corticosteroids (2) 2
internal medicine (2) 2
long-acting β (2) 2
medicine & public health (2) 2
medicine, general & internal (2) 2
muscarinic antagonists - administration & dosage (2) 2
muscarinic antagonists - therapeutic use (2) 2
original (2) 2
pharmacology (2) 2
pharmacology & pharmacy (2) 2
pharmacology/toxicology (2) 2
pharmacotherapy (2) 2
prevention (2) 2
propionate (2) 2
pulmonary disease, chronic obstructive - physiopathology (2) 2
pulmonary/respiratory (2) 2
quinolines - therapeutic use (2) 2
quinuclidines - adverse effects (2) 2
quinuclidines - therapeutic use (2) 2
randomized controlled trials as topic (2) 2
south africa (2) 2
tiotropium (2) 2
tiotropium bromide - administration & dosage (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Chest, ISSN 0012-3692, 2014, Volume 145, Issue 5, pp. 981 - 991
Background Combination long-acting bronchodilator therapy may be more effective than long-acting bronchodilator monotherapy in COPD. Our objectives were to... 
Pulmonary/Respiratory
Journal Article
Chest, ISSN 0012-3692, 09/2006, Volume 130, Issue 3, pp. 647 - 656
To examine the effect of fluticasone propionate, 250 μg/salmeterol, 50 μg combination (FSC 250/50) twice daily on lung hyperinflation and associated measures... 
long-acting β2-agonist | lung hyperinflation | salmeterol | fluticasone propionate | exercise | inhaled corticosteroid | COPD | Exercise | Inhaled corticosteroid | Salmeterol | agonist | Long-acting β | Lung hyperinflation | Fluticasone propionate | INSPIRATORY CAPACITY | DYSPNEA | PERFORMANCE | long-acting beta-agoinst | FLOW LIMITATION | INHALED BRONCHODILATORS | SALMETEROL | PROPIONATE | OBSTRUCTIVE PULMONARY-DISEASE | DYNAMIC HYPERINFLATION | RESPIRATORY SYSTEM | TIOTROPIUM | CRITICAL CARE MEDICINE | Bronchodilator Agents - therapeutic use | Albuterol - pharmacology | Humans | Middle Aged | Male | Pulmonary Disease, Chronic Obstructive - physiopathology | Pulmonary Disease, Chronic Obstructive - pathology | Physical Endurance - physiology | Lung Volume Measurements | Dose-Response Relationship, Drug | Respiratory Mechanics - drug effects | Time Factors | Pulmonary Ventilation - physiology | Female | Adrenergic beta-Agonists - therapeutic use | Bronchodilator Agents - adverse effects | Respiratory Mechanics - physiology | Adrenergic beta-Agonists - adverse effects | Tidal Volume - physiology | Lung - pathology | Salmeterol Xinafoate | Double-Blind Method | Pulmonary Ventilation - drug effects | Adrenergic beta-Agonists - pharmacology | Albuterol - analogs & derivatives | Bronchodilator Agents - pharmacology | Dyspnea - physiopathology | Lung - physiopathology | Androstadienes - pharmacology | Lung - drug effects | Albuterol - therapeutic use | Aged | Androstadienes - therapeutic use | Fluticasone-Salmeterol Drug Combination | Respiratory Function Tests | Androstadienes - adverse effects | Physical Endurance - drug effects | Tidal Volume - drug effects | Albuterol - adverse effects | Drug Combinations | Pulmonary Disease, Chronic Obstructive - drug therapy | Complications and side effects | Lung diseases, Obstructive | Usage | Corticosteroids | Propionates | Research | Drug therapy
Journal Article
International Journal of COPD, ISSN 1176-9106, 02/2017, Volume 12, pp. 745 - 755
Introduction: Patients with COPD who remain symptomatic on long-acting bronchodilator monotherapy may benefit from step-up therapy to a long-acting... 
Umeclidinium/vilanterol | Tiotropium | LAMA | Step-up | LABA | COPD | TRIALS | umeclidinium/vilanterol | METAANALYSIS | EFFICACY | SAFETY | tiotropium | 62.5/25 MCG | OBSTRUCTIVE PULMONARY-DISEASE | RESPIRATORY SYSTEM | step-up | Bronchodilator Agents - administration & dosage | United States | Humans | Middle Aged | Muscarinic Antagonists - adverse effects | Benzyl Alcohols - administration & dosage | Benzyl Alcohols - adverse effects | Male | Pulmonary Disease, Chronic Obstructive - physiopathology | Quinuclidines - administration & dosage | Recovery of Function | Chlorobenzenes - administration & dosage | Forced Expiratory Volume | Tiotropium Bromide - administration & dosage | Time Factors | Female | Surveys and Questionnaires | Bronchodilator Agents - adverse effects | Quinuclidines - adverse effects | Pulmonary Disease, Chronic Obstructive - diagnosis | Argentina | Europe | Tiotropium Bromide - adverse effects | Logistic Models | Treatment Outcome | Lung - physiopathology | Muscarinic Antagonists - administration & dosage | Vital Capacity | Chlorobenzenes - adverse effects | Lung - drug effects | Intention to Treat Analysis | Least-Squares Analysis | South Africa | Aged | Drug Substitution | Pulmonary Disease, Chronic Obstructive - drug therapy | Complications and side effects | Lung diseases, Obstructive | Dosage and administration | Research | Drug therapy | Bronchodilator agents
Journal Article
Drugs in R&D, ISSN 1174-5886, 6/2016, Volume 16, Issue 2, pp. 217 - 227
Journal Article
ERS Monograph, ISSN 2312-508X, 01/2018, Volume 4, Issue 1, p. 73
This multicentre, randomised, double-blind, placebo-controlled, two-period crossover study assessed the effect of umeclidinium/vilanterol (UMEC/VI) on exercise... 
Journal Article
Journal Article
The Journal of Allergy and Clinical Immunology, ISSN 0091-6749, 1998, Volume 101, Issue 2, pp. 188 - 195
Background: Traditional clinical outcomes have demonstrated that salmeterol improves pulmonary function and reduces asthma symptoms. However, they do not... 
asthma | quality of life | pharmacoeconomics | Salmeterol | Pharmacoeconomics | Asthma | Quality of life | ALBUTEROL | SALBUTAMOL | ALLERGY | salmeterol | DISEASE | IMMUNOLOGY | OF-LIFE | Antiasthmatic agents | Care and treatment | Corticosteroids
Journal Article
American Journal of Respiratory and Critical Care Medicine, ISSN 1073-449X, 09/2001, Volume 164, Issue 5, p. 759
Journal Article
Annals of Allergy, Asthma & Immunology, ISSN 1081-1206, 2004, Volume 92, Issue 2, pp. 201 - 207
Journal Article
Journal of chemical education, ISSN 0021-9584, 03/2000, Volume 77, Issue 3, p. 391
Kalberg and Ogren describe the fabrication and use of a simple, low-cost salt pellet press. 
Fabrication | Salt | Science education | Chemistry | Equipment
Journal Article
Chest, ISSN 0012-3692, 10/2003, Volume 124, Issue 4, p. S87
Journal Article
Chest, ISSN 0012-3692, 01/2003, Volume 124, Issue 4, pp. 87S - 87S
Journal Article
Journal of Chemical Education, ISSN 0021-9584, 3/2000, Volume 77, Issue 3, pp. 391 - 392
Directions are provided for the fabrication of an inexpensive IR salt pellet press that may be used easily and quickly by beginning chemistry students.... 
CHEMISTRY, MULTIDISCIPLINARY | EDUCATION, SCIENTIFIC DISCIPLINES | Hydraulic jacks | Chemistry | Usage | Salts | Equipment and supplies | Fourier transform infrared spectroscopy
Journal Article
MAYO CLINIC PROCEEDINGS, ISSN 0025-6196, 05/2002, Volume 77, Issue 5, pp. 437 - 445
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.